Where I would invest $10,000 in the share market

CSL Limited (ASX:CSL) shares and two others could be great places to invest $10,000 today…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

An annual $10,000 investment might not seem like a lot on the surface of it, but over the long-term this level of investment can grow into something much bigger.

According to Fidelity, the local share market has provided an average annual return of 9.1% over the last 30 years.

While there is no guarantee that the share market will provide a similar average return over the next 30 years, if it were to do and you invested $10,000 per year into the share market, in 30 years your investment would have grown to be worth approximately $1.5 million.

With that in mind, here are three shares which I would consider investing that initial $10,000 into:

Bellamy's Australia Ltd (ASX: BAL)

I have been very impressed with the remarkable turnaround of this infant formula company. The company has gone from being on the brink of bankruptcy a year ago to become a market darling once again. In FY 2018 revenue growth is expected in the range of 30% to 35%. But with demand for its products growing strongly and its CFDA accreditation likely to be granted in the next few months, I believe Bellamy's is positioned perfectly to deliver an even stronger result in FY 2019.

BHP Billiton Limited (ASX: BHP)

While it isn't the type of share you can buy and hold forever, I believe the strength of the global economy should mean that BHP has the ability to outperform the market for the next two to three years. Coupled with its generous fully franked dividend, I think this makes the mining giant a great investment idea today.

CSL Limited (ASX: CSL)

In my opinion CSL is one of the highest quality companies in Australia and I believe its shares are capable of providing market-beating returns over the long-term. This is thanks largely to the strength of its core business and fledgling influenza business. Combined I think they will help the biotherapeutics company grow its earnings at an above-average rate for the foreseeable future.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »